Katia Abarca

Pontificia Universidad Católica de Chile

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial”.

Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial

medRxiv(2021)10.1101/2021.03.31.21254494

N/A

4.6DataRank · unranked

59 citations

Katia Abarca, Pablo A. González, Nicolás M. S. Gálvez, Jorge A. Soto, Luisa F. Duarte +41 more

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine

Frontiers in Immunology(2021)10.3389/fimmu.2021.747830

N/A

0.665DataRank · unranked

83 citations

Jorge A. Soto, Liliana A González, Jorge Onrubia Fernández, Luisa F. Duarte, Bárbara M. Schultz +26 more

An inactivated SARS-CoV-2 vaccine is safe and induces humoral and cellular immunity against virus variants in healthy children and adolescents in Chile

medRxiv(2022)10.1101/2022.02.15.22270973

N/A

0.552DataRank · unranked

9 citations

Felipe Melo-González, Cristián Gutiérrez-Vera, Bárbara M. Schultz, Roslye V. Berríos-Rojas, Daniela Rivera-Pérez +49 more

Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults

medRxiv(2022)10.1101/2022.08.22.22279080

N/A

0.241DataRank · unranked

4 citations

Constanza Méndez, Hernán F. Peñaloza, Bárbara M. Schultz, Alejandro Piña-Iturbe, Mariana Ríos +36 more

Immune responses during COVID-19 breakthrough cases in vaccinated children and adolescents

Frontiers in Immunology(2024)10.3389/fimmu.2024.1372193

N/A

0.174DataRank · unranked

2 citations

Constanza Méndez, Benjamín Diethelm‐Varela, Felipe Melo-González, Yaneisi Vázquez, Xing Meng +20 more

A booster dose of an inactivated SARS-CoV-2 vaccine targeting virus variants sustains protective humoral and cellular immunity

BMC Medicine(2025)10.1186/s12916-025-04535-8

N/A

0DataRank · unranked

0 citations

Linmar Rodríguez‐Guilarte, Pablo A. Palacios, Cristián Gutiérrez-Vera, Francisca Román, Daniela Moreno‐Tapia +35 more

A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern

medRxiv(2021)10.1101/2021.11.16.21266350

N/A

0DataRank · unranked

10 citations

Felipe Melo-González, Luisa F. Duarte, Nicolás M. S. Gálvez, Gaspar A. Pacheco, Jorge A. Soto +32 more

Differential immune response induced by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial

medRxiv(2022)10.1101/2022.08.05.22278464

N/A

0DataRank · unranked

0 citations

Gaspar A. Pacheco, Bárbara M. Schultz, Felipe Melo-González, Jorge A. Soto, Luisa F. Duarte +34 more

Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccine

iScience(2025)10.1016/j.isci.2025.113167

N/A

0DataRank · unranked

1 citations

Linmar Rodríguez‐Guilarte, Constanza Méndez, Mariana Ríos, Daniela Rivera, Daniela Moreno‐Tapia +31 more

Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile

Clinical Infectious Diseases(2021)10.1093/cid/ciab823

N/A

0DataRank · unranked

109 citations

Katia Abarca, Pablo A. González, Nicolás M. S. Gálvez, Jorge A. Soto, Luisa F. Duarte +41 more